Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
06/17/1998 | EP0847240A1 Novel embolizing compositions |
06/17/1998 | EP0636142B1 Lactam peptides having hle inhibiting activity |
06/17/1998 | EP0635003B1 Perhydroisoindole derivatives as p substance antagonists |
06/17/1998 | CN1185156A Novel substituted tetrahydropyrano £3, 2-d| oxazolones, the prodn. and pharmaceutical use thereof |
06/17/1998 | CN1185106A Use of carbazole compounds for treating congestive heart failure |
06/17/1998 | CN1184664A Emulsion for lowering blood-lipid, and method for preparing same |
06/17/1998 | CN1038751C Cyclopeptides |
06/16/1998 | US5767293 Antitumor |
06/16/1998 | US5767274 Treating tumors or restenosis |
06/16/1998 | US5767268 Treatment of disorders characterized by excessive or destructive proliferation of smooth muscle cells |
06/16/1998 | US5767262 Isolated dna comprising sequence encoding smooth muscle cell lim polypeptide |
06/16/1998 | US5767241 Soluble form of GMP-140 |
06/16/1998 | US5767160 Method and formulation of stimulating nitric oxide synthesis |
06/16/1998 | US5767159 Improving the capacity of muscles for work and shortening the time for recovery after exercise or various therapies, e.g.postoperative surgery, respiratory disorders |
06/16/1998 | US5767116 Bicyclic aromatic compounds as therapeutic agents |
06/16/1998 | US5767115 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
06/16/1998 | US5767088 Useful for treating pain, inflammation, smooth muscle contraction and inducing vasodilation |
06/16/1998 | US5766940 Plasmid and plasmid vector |
06/16/1998 | US5766886 Modified antibody variable domains |
06/16/1998 | US5766838 Manual quantitating the number of leukocyte binding tissue cell over a defind are of tissue sample section |
06/16/1998 | US5766610 Useful for treatment of mammalian skin and hair, rheumatism, resipiratory system disorder, cardiovascular and vision disorders |
06/16/1998 | CA2224885A1 Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparations comprising them |
06/16/1998 | CA2165779C Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
06/16/1998 | CA2132831C Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans |
06/16/1998 | CA2065965C Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist |
06/13/1998 | CA2219613A1 Crystalline form of the doxazosin mesylate and process for its production |
06/11/1998 | WO1998024916A1 Novel calpaines, production and use thereof |
06/11/1998 | WO1998024914A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
06/11/1998 | WO1998024902A1 Adaptor protein frs2 and related products and methods |
06/11/1998 | WO1998024892A1 Ve-cadherin promoter and its uses |
06/11/1998 | WO1998024809A1 Peptides agonists of bradykinine b2 receptor |
06/11/1998 | WO1998024805A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
06/11/1998 | WO1998024790A1 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application |
06/11/1998 | WO1998024784A1 Substituted sulfonic acid n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds |
06/11/1998 | WO1998024782A2 Substituted pyrimidine compounds and their use |
06/11/1998 | WO1998024780A2 Substituted pyrimidinone and pyridinone compounds and their use |
06/11/1998 | WO1998024771A1 Benzamide derivatives having a vasopressin antagonistic activity |
06/11/1998 | WO1998024766A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
06/11/1998 | WO1998024762A1 Vitamin d3 derivatives |
06/11/1998 | WO1998024482A2 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them |
06/11/1998 | WO1998024447A1 Use of nk-1 receptor antagonists for treating cognitive disorders |
06/11/1998 | WO1998024437A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors |
06/11/1998 | WO1998024430A1 Pharmaceutical compositions containing n-sulphonyl indolin derivatives |
06/11/1998 | WO1998024427A2 Compositions and methods for treating or preventing inflammatory diseases |
06/11/1998 | CA2607067A1 Compositions and methods for treating or preventing inflammatory diseases |
06/11/1998 | CA2274304A1 Novel calpaines, production and use thereof |
06/11/1998 | CA2274249A1 Inhibitors of interleukin-1.beta. converting enzyme |
06/11/1998 | CA2274145A1 Adaptor protein frs2 and related products and methods |
06/11/1998 | CA2274048A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors |
06/11/1998 | CA2274011A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
06/11/1998 | CA2273990A1 Pharmaceutical compositions containing n-sulphonyl indolin derivatives |
06/11/1998 | CA2273853A1 Use of nk-1 receptor antagonists for treating cognitive disorders |
06/11/1998 | CA2273190A1 Peptides agonists of bradykinine b2 receptor |
06/11/1998 | CA2272994A1 Ve-cadherin promoter and its uses |
06/11/1998 | CA2272148A1 Vitamin d3 derivatives |
06/11/1998 | CA2271072A1 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application |
06/11/1998 | CA2245699A1 Substituted sulfonic acid n-¬(aminoiminomethyl)phenylalkyl}-azaheterocyclamide compounds |
06/11/1998 | CA2224131A1 Novel human 11 cb splice variant |
06/10/1998 | EP0846763A2 A protein phosphatase 1 binding protein, R5 |
06/10/1998 | EP0846694A1 Morphinan derivative and its pharmaceutical applications |
06/10/1998 | EP0846688A1 New imidazoline derivatives having affinity for the imidazoline receptor |
06/10/1998 | EP0846687A1 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors |
06/10/1998 | EP0846685A1 3-Hydroxypyridine-2-carboxylic acid amide esters, their preparation and their use as medicaments |
06/10/1998 | EP0846464A2 Use of glycogen phosphorylase inhibitor for reducing non-cardiac tissue damage resulting from ischemia |
06/10/1998 | EP0846116A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists |
06/10/1998 | EP0846108A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists |
06/10/1998 | EP0845992A1 Method of promoting angiogenesis |
06/10/1998 | EP0845986A1 Pharmaceutical composition for treating cardiovascular diseases containing 3-(2,2,2-trimethylhydrazinium) propionate and gamma-butyrobetaine |
06/10/1998 | EP0831817A4 Antigen-processing cell-targeted conjugates |
06/10/1998 | EP0710113B1 Preparation for improving the blood supply containing hard magnetic particles |
06/10/1998 | EP0674508B1 4-guanidinobutyramide for improving blood circulation |
06/10/1998 | DE19652374A1 Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung Use of endothelin-conjugates in therapy, new endothelin conjugates, compositions comprising them, and to processes for their preparation |
06/10/1998 | DE19650975A1 Neue heterocyclisch substituierte Benzamide und deren Anwendung New heterocyclic-substituted benzamides and their application |
06/10/1998 | CN1184483A Fucopeptides |
06/10/1998 | CN1184470A Thienyl-, Furyl-, Pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
06/10/1998 | CN1184104A 3 -hydroxy -pyridine -2 -carboxylic amide ester, and its preparation and its application as medicine |
06/10/1998 | CN1183960A Controlled release pharmaceutical compositions for oral administration containing nifedipine as active substance |
06/10/1998 | CN1038680C Dihydronaphtho £1, 2-b| pyrane derivative and its producing process and use |
06/09/1998 | US5763621 Reaction of acid compound with hydroxylamine compound or amidation of acid |
06/09/1998 | US5763614 1,4-dihydropyridine derivatives and methods of producing the same |
06/09/1998 | US5763569 Polypeptides as calcium receptors to generate antibodies |
06/09/1998 | US5763567 Human amino acid sequences which can bind to and/or neutralize heparin |
06/09/1998 | US5763496 Selected from catechols and ortho-methoxyphenols |
06/09/1998 | US5763489 Naphthalene derivatives as prostaglandin I2 agonsists |
06/09/1998 | US5763487 Skin disorders, cardiovascular disorders and cosmetics |
06/09/1998 | US5763458 1-phenylalkanone 5-HT4 receptor ligands |
06/09/1998 | US5763220 Human apoptosis-related calcium-binding protein |
06/09/1998 | US5762952 Transdermal delivery of active drugs |
06/05/1998 | CA2223317A1 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors |
06/04/1998 | WO1998023619A1 Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases |
06/04/1998 | WO1998023611A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists |
06/04/1998 | WO1998023610A1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists |
06/04/1998 | WO1998023609A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists |
06/04/1998 | WO1998023608A1 Novel integrin receptor antagonists |
06/04/1998 | WO1998023603A1 Dimesylate salts of neuropeptide y ligands |
06/04/1998 | WO1998023596A1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
06/04/1998 | WO1998023591A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
06/04/1998 | WO1998023581A1 Benzamidoaldehydes and their use as cysteine protease inhibitors |
06/04/1998 | WO1998023565A2 Aminoguanidines and alkoxyguanidines as protease inhibitors |
06/04/1998 | WO1998023299A2 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof |